Companies / Oric Pharmaceuticals, Inc. / Activity
Activity — Oric Pharmaceuticals, Inc.
16 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | Piscitelli Dominic Executive | Sell | Common Stock | $702.7K | -52K -43.28% | 68,148 0.07% of shares | medium |
| Feb 24, 2026 | Piscitelli Dominic Executive | Exercise | Common Stock | $226.7K | +52K +76.30% | 120,148 0.12% of shares | low |
| Jan 16, 2026 | Heyman Richard A. Director | Sell | Common Stock | $42.0K | -4K -7.73% | 41,800 0.04% of shares | low |
| Jan 16, 2026 | Heyman Richard A. Director | Sell | Common Stock | $38.4K | -3K -1.48% | 213,072 0.21% of shares | low |
| Feb 24, 2026 | Piscitelli Dominic Executive | Exercise | Stock Option (right to buy) | — | -52K -26.46% | 144,500 0.14% of shares | low |
| Jan 2, 2026 | Piscitelli Dominic Executive | Grant | Restricted Stock Unit | — | +35K | 34,500 0.03% of shares | low |
| Jan 2, 2026 | Piscitelli Dominic Executive | Grant | Stock Option (right to buy) | — | +207K | 206,500 0.20% of shares | low |
| Jan 2, 2026 | You Angie Director | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 2, 2026 | Chacko Jacob CEO | Grant | Restricted Stock Unit | — | +113K | 112,500 0.11% of shares | low |
| Jan 2, 2026 | Chacko Jacob CEO | Grant | Stock Option (right to buy) | — | +675K | 675,000 0.65% of shares | low |
| Jan 2, 2026 | Multani Pratik S Executive | Grant | Restricted Stock Unit | — | +36K | 35,500 0.03% of shares | low |
| Jan 2, 2026 | Multani Pratik S Executive | Grant | Stock Option (right to buy) | — | +214K | 214,000 0.21% of shares | low |
| Jan 2, 2026 | Heyman Richard A. Director | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 2, 2026 | Dier Mardi Director | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 2, 2026 | Kunkel Lori Anne Director | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.04% of shares | low |
| Jan 2, 2026 | Hoerter Steven L. Director | Grant | Stock Option (right to buy) | — | +40K | 40,000 0.04% of shares | low |